Your browser doesn't support javascript.
loading
Predicting monoclonal antibody binding sequences from a sparse sampling of all possible sequences.
Bisarad, Pritha; Kelbauskas, Laimonas; Singh, Akanksha; Taguchi, Alexander T; Trenchevska, Olgica; Woodbury, Neal W.
Affiliation
  • Bisarad P; School of Molecular Sciences, Arizona State University, Tempe, AZ, USA.
  • Kelbauskas L; Center for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, AZ, USA.
  • Singh A; Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Taguchi AT; Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
  • Trenchevska O; Center for Molecular Design and Biomimetics, Biodesign Institute, Arizona State University, Tempe, AZ, USA.
  • Woodbury NW; Biomorph Technologies, Chandler, AZ, USA.
Commun Biol ; 7(1): 979, 2024 Aug 12.
Article in En | MEDLINE | ID: mdl-39134636
ABSTRACT
Previous work has shown that binding of target proteins to a sparse, unbiased sample of all possible peptide sequences is sufficient to train a machine learning model that can then predict, with statistically high accuracy, target binding to any possible peptide sequence of similar length. Here, highly sequence-specific molecular recognition is explored by measuring binding of 8 monoclonal antibodies (mAbs) with specific linear cognate epitopes to an array containing 121,715 near-random sequences about 10 residues in length. Network models trained on resulting sequence-binding values are used to predict the binding of each mAb to its cognate sequence and to an in silico generated one million random sequences. The model always ranks the binding of the cognate sequence in the top 100 sequences, and for 6 of the 8 mAbs, the cognate sequence ranks in the top ten. Practically, this approach has potential utility in selecting highly specific mAbs for therapeutics or diagnostics. More fundamentally, this demonstrates that very sparse random sampling of a large amino acid sequence spaces is sufficient to generate comprehensive models predictive of highly specific molecular recognition.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal Limits: Humans Language: En Journal: Commun Biol Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal Limits: Humans Language: En Journal: Commun Biol Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido